In This Section

Home / Learn / Cancer Types / Lung Cancer

Lung Cancer

Lung cancer remains the leading cause of cancer-specific mortality in the United States, with non-small cell lung cancer (NSCLC) accounting for the vast majority (80 – 85 percent) of newly diagnosed cases.

While fragmentation of the healthcare system can impede consistent access to equitable care, gaps in the quality of cancer care delivery persist among certain patient populations due to prevailing social determinants of health1 and contribute to suboptimal outcomes.2–3

Developing quality improvement programs that aim to reduce disparities and improve the standard of care received by patients with lung cancer are a key priority in ACCC’s educational portfolio. Leverage our recent research and explore practical, actionable tools to implement in your cancer program or practice today.

Defining Quality Care

ACCC has designed a quality benchmark to define ideal care for patients with stages III and IV non-small cell lung cancer, with an emphasis on leveraging the expertise of the multidisciplinary cancer team.
Explore Quality NSCLC Recommendations

“We have a paradox that with all the advances in research… there is a major gap in applying them to care. The nature of the multidisciplinary team is important and lung cancer is not just the realm of medical oncology—it's the realm of many different disciplines. Our emphasis in this work is uniting the different pieces of lung cancer care… [to find] the best way to care for patients.

David SpiegelDavid Spigel, MD,
Chief Scientific Officer; Director, Lung Cancer Research Program, Tennessee Oncology; Principal Investigator, Sarah Cannon Research Instituteend-quote

Explore this program:

Infographics & Video Summaries

Access new recommendations for defining high-quality care for this patient population through scientific presentations, infographics, and video summaries—broken down by multidisciplinary care team focus.

NSCLC Resource Library

Explore this robust resource bank of curated nationally-available materials to support your NSCLC patients. Filter by target audience (your clinical care team or your patients), cancer stage, or by keyword.

Improving Care Coordination

In order to identify and reduce barriers to care experienced by lung cancer patients covered by Medicaid, ACCC created a model framework to help cancer programs evaluate their current state of care coordination and identify areas of improvement. Assess Your Cancer Program

“The care coordination tool that ACCC developed [the Model] really helped us formally evaluate our program. We knew that patients diagnosed with lung cancer were getting lost in our system. We had a lot of late-stage lung cancer patients, and we needed to improve our case planning so we could identify those patients sooner."

sherri costa (1)Sherri Costa, MS, RN, AOCNS,
Manager of Cancer Support Services & Quality Improvement Coordinator, Ascension Wheaton Memorial Medical Centerend-quote

Explore this program:

6 Steps to Improve Care Coordination
See how this free, interactive online tool can help evaluate the current state of care coordination for lung cancer patients at your cancer program or practice, and identify focus areas for improvement and next steps.

Access Full Report
To leverage assessment results for the development of quality improvement projects, the Full Report is an ideal starting place. Its 12 Assessment Areas map to more than 100 quality measures for collecting and reporting data.

ACCCBuzz Blog Posts


From Oncology Issues

  •  An Optimal Care Coordination Model for Medicaid Patients with Lung Cancer: Rationale, Development, and Design
    Randall A. Oyer, MD, et al.
    The OCCM was designed to be a usable framework that offers lung cancer programs, regardless of setting, size, and resource level, and the flexibility to conduct continuous assessments of care coordination practices and measure strengths and opportunities in the pursuit of optimal patient outcomes.
  •  Robotic Bronchoscopy
    Amy Hindman
    Early identification, staging, and diagnosis of lung cancer is critical to improving patient outcomes. However, current diagnostic options are limited in accuracy, safety, and invasiveness—only 15 percent of patients with lung cancer are diagnosed at an early stage. Read how Fox Chase Cancer Center has implemented new flexible robotic endoscopic technology to diagnose hard-to-reach lung nodules with greater precision than ever before.
  •  A Small, Island Community Hospital Removes Barriers to Lung Cancer Screening and Detection
    By Donna Delfera, RN; Micayla Albers; Lysle Ailstock, MD; and Charles Shelton, MD
    Because of its growing retirement-age population and its unique location on a barrier island, The Outer Banks Hospital saw patients with lung cancer presenting at too late a stage for curative treatment. Learn how the hospital created an LDCT program and partnered with local providers and community cancer centers to identify patients with lung cancer at an earlier stage.


  1. Institute of Medicine. 2013.
  2. Slatore CG, et al. Am J Respir Crit Care Med 2010;182:1195-1205.
  3. Pezzi TA, et al. JAMA Netw Open 2020;3:e203277.

In the News